ArticleCentral European journal of urology2025
Postoperative complications, emergency department utilisation, and readmission after radical cystectomy.
Article in Central European journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A narrative review of the state of urinary diversion: ileal conduit, neobladder, continent cutaneous, and cutaneous ureterostomy.Translational andrology and urology · 2026Review
- Single-Stoma Cutaneous Ureterostomy After Radical Cystectomy: A Contemporary Narrative Review.Current oncology (Toronto, Ont.) · 2026Review
- Comparing benign to malignant cystectomy: complications, emergency department utilization, readmissions, and socioeconomic status.International urology and nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There is minimal research on the types of complications patients experience after radical cystectomy (RC). Moreover, the impact of these complications is not well qualified. The primary purpose of this study is to qualify complications after RC and quantify rates of emergency department (ED) utilisation and readmissions to the hospital. The secondary purpose is to associate risk factors for ED visits and hospital readmission. Material and methods: Patients were retrospectively analysed, who underwent RC for bladder cancer. ED visits within 90 days of discharge from RC and readmission at both 30 and 31-90 days of discharge were collected. Complications were graded using the Clavien-Dindo system and classified using the Memorial Sloan-Kettering Cancer Center complication system. Results: Three hundred and eighty-six patients were included. The in-house complication rate before discharge was 36%, and the 90-day complication rate after discharge was 54.8%. 33.7% of patients had ≥1 ED visit postoperatively, 18.7% were readmitted within 30 days, and 17.3% within 31-90 days of discharge. The primary reason for ED presentation, readmission at 30 and 31-90 days was infection. Cutaneous ureterostomy (CU) was associated with greater likelihood of presentation to the ED and readmission 31-90 days postoperatively (p <0.01). Overall survival (OS) was worse in patients who presented to the ED and/or were readmitted at both the 30- and 31-90-day marks (p <0.01). Conclusions: ED utilisation and readmission rates after RC are high. The most common complication is infection. Patients with a CU are at higher risk for healthcare utilisation. OS is worse in patients with an ED visit or readmission to the hospital, and these patients may require closer monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.